Cardiovascular disease: identifying and supporting people most at risk of dying early

it was not possible to undertake a quantitative synthesis of the results. Cost-effectiveness analysis An economic model was constructed to incorporate data from the reviews of effectiveness and cost effectiveness. The approach was applied to all 4 cost-effectiveness reports. The results are reported in: • 'Economic analysis of interventions to improve the use of statins interventions in the general population.' • 'Economic analysis of interventions to improve the use of statins in disadvantaged populations.' • 'Economic analysis of interventions to improve the use of smoking cessation interventions in the general population.' • 'Economic analysis of interventions to improve the use of smoking cessation interventions in disadvantaged populations.' An additional, supplementary economic analysis was undertaken to answer a number of questions posed by PHIAC. See the economic analysis reports. Fieldwork Fieldwork was carried out to evaluate the relevance and usefulness of NICE guidance for practitioners and the feasibility of implementation. It was conducted with practitioners and commissioners who are involved in smoking cessation services and statin provision. Participants included: strategic health authority directors, primary care trust directors of public health and public health teams, commissioning managers and performance managers, GPs and primary care nurses. They also included community pharmacists, health trainers
